Influence of vascular endothelial growth factor (VEGF) and endostatin on coronary artery lesions in Kawasaki disease
![]() |
Kim, Seon A
(Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Jung, Bum Suk (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Yoon, Jong Seo (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Han, Ji Whan (Department of Pediatrics, College of Medicine, The Catholic University of Korea) Lee, Joon Sung (Department of Pediatrics, College of Medicine, The Catholic University of Korea) |
1 | Kim DS. Kawasaki disease. Yonsei Med J 2006;47:759-72 DOI ScienceOn |
2 | Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Physician 2006;74:1141-8 |
3 | Schroh AM, Dominguez P, Laghezza LB, Melonari PA, Olguin M, Miatello R. Kawasaki disease: heart disease during childhood. Rev Esp Cardiol 2006;59:387-90 DOI ScienceOn |
4 | Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial grow th factor in Kawasaki disease. Pediatr Res 1998;44: 596-9 DOI ScienceOn |
5 | Park MH, Jung HL, Yang JH, Shim JY, Kim DS, Shim JW, et al. Serum vascular endothelial growth factor as a predictive risk factor for the occurrence of coronary artery lesions in Kawasaki disease. J Korean Pediatr Soc 2003;46: 811-6 |
6 | Takeshita S, Kawamura Y, Takabayashi H, Yoshida N, Nonoyama S. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Clin Exp Immunol 2005;139:575-9 DOI ScienceOn |
7 | Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independentl zinc binding. EMBO J 1999;18:4414-23 DOI ScienceOn |
8 | Ohno T, Yuge T, Kariyazono H, Igarashi H, Joh-o K, Kinugawa N, et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2002;161:105-11 DOI |
9 | Kim MS, Kim KS. The study of serum vascular endothelial growth factor in the acute febrile phase of Kawasaki disease. J Korean Pediatr Soc 2002;45:114-9 |
10 | Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47:232-4 DOI ScienceOn |
11 | Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr 2004;16:508-14 DOI ScienceOn |
12 | Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999;83:337-9 DOI ScienceOn |
13 | asukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002;105:766-9 DOI ScienceOn |
14 | Schuch G, Heymach JV, Nomi M, Machluf M, Force J, Atala A, et al. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 2003;63:8345-50 |
15 | Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T. Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2000;159:424-9 DOI |
16 | Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, et al. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 2004;56:953-9 DOI ScienceOn |
17 | Royle J, Burgner D, Curtis N. The diagnosis and management of Kawasaki disease. J Paediatr Child Health 2005;41: 87-93 DOI ScienceOn |
18 | Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 2000;101:2935-41 DOI ScienceOn |
19 | Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki syndrome. Arthritis Rheum 1998;41:1538-47 DOI ScienceOn |
20 | Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan : Ministry of Health and Welfare, 1984 |
21 | Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Ha moto I, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res 2001;49:74-80 DOI ScienceOn |
22 | Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-20 DOI |
![]() |